Peter J. Thornton

This profile gathers the share dealings of Peter J. Thornton in Avadel Pharmaceuticals PLC, where the filings describe the role as board member. The record holds 7 filings, for trades running from 21 September 2017 to 12 February 2026.

Purchases make up the whole of the open-market record (3 purchases, €199k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants.

The median purchase comes to €79k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 12 February 2026 with a transaction (€2.0M) in Avadel Pharmaceuticals PLC. The last insider purchase was made public on 14 January 2025, 648 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.